Side Effects of Orlistat: Causes and Tips

The side effects of orlistat are predominantly gastrointestinal and arise directly from how the medicine works. By blocking the enzymes that digest dietary fat, orlistat causes unabsorbed fat to pass through the bowel, leading to oily stools, urgency and flatulence. These effects are closely tied to fat intake at each meal, meaning diet plays a central role in how troublesome symptoms become. This article covers the most common and serious side effects, how long they last, who is most at risk, and practical steps to reduce digestive discomfort while taking orlistat.

What are the most common side effects of orlistat?

The most common side effects of orlistat are oily stools, oily spotting, urgent or frequent bowel movements, flatulence and abdominal cramping, all caused by unabsorbed fat passing through the gut.

The most common side effects of orlistat are gastrointestinal in nature, arising directly from the medicine's mechanism of action. Orlistat works by inhibiting pancreatic and gastric lipases, the enzymes responsible for breaking down dietary fat in the gut.^[8][1] When fat is not absorbed, it passes through the digestive tract and is excreted, which causes a predictable range of bowel-related effects.

The side effects most frequently reported include:

• Oily or fatty stools (steatorrhoea)

• Oily spotting on underwear

• Frequent or urgent bowel movements

• Flatulence, sometimes with an oily discharge

• Loose or liquid stools

• Abdominal discomfort or cramping

• Increased number of bowel movements

These effects arise from the medicine's mechanism rather than from direct tissue damage, but they can be troublesome and persistent symptoms should be discussed with a GP or pharmacist. The NHS notes that these effects are more pronounced when a person eats a meal that is high in fat, which is why dietary modification is an important part of orlistat treatment.

Orlistat is available in two forms in the UK: a prescription-strength capsule (120 mg, three times daily with meals) and an over-the-counter version (60 mg, sold as Alli).^[6][7] Both share the same side effect profile, though the lower dose may produce milder symptoms in some people. Because these effects are so closely linked to fat intake, many people find that they diminish naturally as they adjust their diet to reduce fat content.

Bolt Pharmacy is a GPhC-registered UK online pharmacy offering online weight-management consultations, with prescriber review and pharmacist support, where a range of clinically appropriate options may be considered.

Are there any serious side effects I should watch out for?

Rare but serious side effects include liver injury, kidney stones and pancreatitis; stop orlistat and contact your GP promptly if jaundice, dark urine or severe abdominal pain develop.

Serious side effects of orlistat are uncommon but do occur, and some require prompt medical attention. The most clinically significant concern is liver injury. The MHRA has issued guidance noting that rare cases of severe liver damage have been reported in people taking orlistat, though a definitive causal link has not been established in all cases.^[5][1] Symptoms that may suggest liver problems include:

• Yellowing of the skin or whites of the eyes (jaundice)

• Dark urine or pale stools

• Persistent nausea or vomiting

• Severe abdominal pain

• Unusual fatigue or loss of appetite

If any of these symptoms develop, you should stop taking orlistat and contact your GP promptly. If symptoms are severe or rapidly worsening, seek urgent assessment via NHS 111.

Orlistat can also reduce the absorption of fat-soluble vitamins, specifically vitamins A, D, E and K.^[1][4] Prolonged deficiency of these vitamins can have consequences for bone health, immune function and blood clotting. For this reason, people taking orlistat long-term are often advised to take a daily multivitamin supplement containing these vitamins, taken at a time separate from the orlistat dose, such as at bedtime.^[1][2]

There have also been post-marketing reports of kidney stones (oxalate nephrolithiasis) associated with orlistat use, particularly in people with pre-existing kidney conditions.^[1][9] Cases of pancreatitis have also been reported in association with orlistat use; anyone experiencing severe or persistent abdominal pain should seek medical review.

Suspected side effects can be reported to the MHRA via the Yellow Card scheme at yellowcard.mhra.gov.uk.

How long do orlistat side effects usually last?

Gastrointestinal side effects are worst in the first few weeks and improve as dietary fat is reduced, but they can return at any time if a high-fat meal is eaten.

Orlistat's gastrointestinal side effects are most pronounced during the first few weeks of treatment and often improve as dietary habits change and fat intake is reduced. For many people, the frequency and severity of oily stools, urgency and flatulence reduce over the initial weeks, particularly once fat intake is consistently kept at a reduced level in line with NHS and NICE guidance on using orlistat alongside a calorie-controlled, reduced-fat diet.

It is important to understand that orlistat's side effects are not a fixed feature of the medicine but are closely tied to what is eaten at each meal. A single high-fat meal can trigger significant symptoms even in someone who has been taking orlistat for months without difficulty. In this sense, the side effects do not fully resolve over time in the way that, for example, nausea from some other medicines might; they remain latent and can return whenever dietary fat intake is high.

For people who continue to experience troublesome symptoms beyond the initial adjustment period despite following a low-fat diet, it is worth discussing this with a GP or pharmacist. Orlistat is available at fixed doses (60 mg or 120 mg, three times daily with meals); the dose is not adjusted, but the dose for a particular meal may be omitted if that meal is skipped or contains no fat. If symptoms remain unmanageable, an alternative weight-management approach may be more appropriate.

Vitamin deficiency, if it develops, is a slower process and may not produce noticeable symptoms for months. This is why consistent use of a multivitamin supplement is recommended throughout the course of treatment, with clinical review if deficiency is suspected. If orlistat is stopped, fat absorption returns to normal relatively quickly, and any ongoing gastrointestinal symptoms related to the medicine should resolve within a few days of discontinuation.

Who is more likely to experience side effects with orlistat?

People eating a high-fat diet are most at risk; those with kidney disease, liver conditions, or taking warfarin, ciclosporin or levothyroxine require additional caution or monitoring.

People who eat a diet high in fat are significantly more likely to experience orlistat's gastrointestinal side effects, because the medicine's effects are directly proportional to the amount of unabsorbed fat passing through the gut. This is the single strongest predictor of symptom severity, and it applies regardless of age, sex or other health factors.

Beyond dietary habits, certain groups warrant additional caution:

• People with chronic kidney disease may be at higher risk of oxalate-related kidney complications, and orlistat should be used with care in this group.

• People with pre-existing liver conditions should discuss the rare risk of liver injury with their GP before starting treatment.

• People taking warfarin or other anticoagulants may experience changes in their INR, because reduced vitamin K absorption can affect clotting. Regular INR monitoring is advisable.

• People taking ciclosporin should avoid orlistat, as it can significantly reduce ciclosporin absorption, which may affect transplant management.^[1][16] This combination is not recommended; consult the prescribing information and transplant team.

• People with diabetes may find that blood glucose control improves with weight loss, potentially requiring adjustment of antidiabetic medicines.

• People taking levothyroxine should take orlistat and levothyroxine at least four hours apart, as absorption of the thyroid medicine may be affected.^[1][17] Thyroid function should be monitored clinically.

Orlistat is licensed for use in adults in the UK. Use in children under 12 years of age is not licensed. If use in adolescents is being considered, this should only occur under specialist supervision and with reference to current clinical guidance.

Orlistat is not recommended during pregnancy or breastfeeding.^[1][2] People using oral contraceptives should be aware that severe diarrhoea can reduce the absorption and effectiveness of the pill; additional contraception should be used if this occurs.^[9][10] Anyone with a history of malabsorption syndromes or cholestasis should not take orlistat.

Tips for reducing digestive side effects while taking orlistat

Keeping fat intake to around 15 g per meal, spreading fat evenly across meals, and taking a multivitamin at bedtime are the most effective strategies for reducing orlistat's digestive side effects.

Reducing fat intake is the most effective strategy for minimising orlistat's digestive side effects, and this is also central to the medicine's intended purpose. NICE guidance on weight management recommends that orlistat is used alongside a calorie-controlled, reduced-fat diet rather than as a standalone intervention.^[11][2] Consumer-facing materials for the 60 mg over-the-counter product (Alli) suggest keeping fat intake to no more than approximately 15 grams per meal as a practical target; people taking the prescription 120 mg dose should follow the dietary advice given by their prescriber or pharmacist.^[12]

The following practical steps can help manage side effects day to day:

• Spread fat intake evenly across three meals rather than consuming most fat in one sitting, as a single high-fat meal is the most common trigger for acute symptoms.

• Read food labels carefully, paying attention to total fat content per serving rather than per 100 g.

• Take orlistat with each main meal or up to one hour after, as directed. If a meal is skipped or contains no fat, the dose for that meal should be omitted rather than taken at another time.

• Take a multivitamin supplement containing vitamins A, D, E and K at bedtime, separate from orlistat doses, to offset reduced fat-soluble vitamin absorption.

• Keep a food diary to identify which meals or food types are associated with worse symptoms, allowing targeted adjustments.

• Wear dark or patterned underwear during the initial weeks of treatment, as oily spotting can occur unpredictably, particularly early on.

• Stay well hydrated, as adequate fluid intake supports digestive comfort generally.

If symptoms remain disruptive despite these measures, speak to your GP or pharmacist. They can review whether the timing of doses needs adjustment or whether a different approach to weight management would be more suitable for your circumstances. Orlistat is available at fixed doses and is not dose-adjusted, but omitting a dose when a meal is fat-free or skipped is appropriate and may help reduce symptoms.

Scientific References

1. Xenical 120 mg hard capsules – Summary of Product Characteristics.
2. Orlistat: a medicine to treat obesity.
3. Alli (previously Orlistat GSK) – European Medicines Agency EPAR.
4. Orlistat – Drugs – BNF – NICE.
5. Orlistat safety update.
6. XENICAL, INN-orlistat – EMA Product Information.
7. Xenical 120 mg – Patient Information Leaflet.
8. Xenical, INN-Orlistat – EMA Scientific Discussion.
9. Orlistat-associated adverse effects and drug interactions.
10. Orlistat – Interactions – BNF – NICE.
11. Obesity – Final Scope (TA1026) – National Institute for Health and Care Excellence.
12. Alli 60 mg – Patient Information Leaflet.
13. Orlistat enhances warfarin effect.
14. Warfarin – Interactions – BNF – NICE.
15. Weight management and current options in pharmacotherapy: orlistat and sibutramine. Clinical Therapeutics.
16. Pharmacokinetic evaluation of the possible interaction between selected concomitant medications and orlistat at steady state in healthy subjects. Journal of Clinical Pharmacology.
17. Levothyroxine: a medicine for an underactive thyroid.
18. Factors Affecting Gastrointestinal Absorption of Levothyroxine: A Review. Clinical Therapeutics.

Frequently Asked Questions